Latest News
Featured News
European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 10-12 December 2025 in London
Kate Young, Samantha Paston, Heather Shaw, Pippa Corrie, Sarah Danson, Miranda Payne, Poulam Patel, Ioannis Karydis, Satish Kumar, Clare Barlow, Rebecca Lee, Martin Highley, Kellati Prasad, Georgia Goodhew, Gaëlle Cane, Joseph Chadwick, Sabaria Shah, Nermeen Varawalla...
Select the category
Scancell in-licenses Vaccitech technology to advance Modi-2 towards the clinic
37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), 8-12 November 2022 in Boston, MA, USA
First patient dosed in the expansion phase of the monotherapy arms of ModiFY
Interim Report 31st October 2022
Preliminary Results for the year ended 30 April 2022
EuroMAbNet 6th Antibody Validation Workshop and 12th Meeting, Hamburg, 22-24 September 2022
Scancell signs Commercial License Agreement with Genmab
Scancell Change of Registered Office
First patient dosed in Cohort 2 of the ModiFY Phase 1 clinical trial
Scancell to produce and clinically validate T cell redirecting bispecific antibodies
Phase 2 SCOPE trial of SCIB1 vaccine in metastatic melanoma patients expanded
First patient dosed in Modi-1 Phase 1 clinical trial
No results found.
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.